LINK HERE: Forbes story: J&J baby medicine "halo effect" for failed hips, defibrillators, stents
Under the cover of a respected purveyor of baby products is an aggressive and very profitable medical device industry.
When the priority of a business entity selling implantable medical devices is solely profit there must be regulation and judicial accountability to provide for patient safety.
Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: @JjrkCh
Wednesday, February 22, 2012
Resigned J&J CEO Weldon on "halo" effect of baby products/medical devices marketing
Labels:
adverse events,
arthroplasty,
ASR hip,
Congress,
DePuy,
entitlement,
FDA,
IOM,
joint replacement,
justice,
patient safety,
post-market data,
product recall,
revision surgery,
Riegel v. Medtronic
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment